Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Med Mycol ; 50(8): 818-28, 2012 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-22587733

RESUMO

Invasive aspergillosis is a major cause of mortality in immunocompromised patients and therapeutic options are often limited, thus a vaccine would be desirable. We presently studied acid-stable cell-wall mannan (α-1, 6-linked backbone highly branched with α-1, 2; α-1, 3; and ß-1, 2-linked manno-oligomers) derived from C. albicans, with or without conjugation to bovine serum albumin (BSA), as a vaccine against systemic aspergillosis. Mice were vaccinated subcutaneously with mannan or mannan-BSA conjugate weekly 3 times, ending 2 weeks prior to infection with A. fumigatus conidia. Results showed that the protection induced by mannan is dose-dependent; 12 mg unconjugated mannan alone or > 0.3 mg mannan-BSA consistently enhanced survival (P < 0.05). Fungal burdens in brains and kidneys were reduced after > 0.3 mg of mannan-BSA (all P < 0.05). Mannan-induced protection was improved about 40-fold by conjugation of BSA to mannan. Mannan-BSA (500 kDa) was more protective than 40 kDa mannan-BSA. Mannan is a candidate for a cross-protective conjugate fungal vaccine.


Assuntos
Aspergilose/prevenção & controle , Vacinas Fúngicas/imunologia , Mananas/imunologia , Vacinação/métodos , Animais , Aspergilose/imunologia , Candida albicans/química , Candida albicans/imunologia , Vacinas Fúngicas/administração & dosagem , Masculino , Mananas/administração & dosagem , Mananas/isolamento & purificação , Camundongos , Vacinas Conjugadas/administração & dosagem , Vacinas Conjugadas/imunologia
2.
Vaccine ; 29(9): 1745-53, 2011 Feb 17.
Artigo em Inglês | MEDLINE | ID: mdl-21219976

RESUMO

Heat-killed Saccharomyces cerevisiae (HKY) used as a vaccine protects mice against systemic aspergillosis and coccidioidomycosis. Little is known about the immune response induced by HKY vaccination, consequently our goal was to do an analysis of HKY-induced immune responses involved in protection. BALB/c mice were vaccinated subcutaneously 3 times with HKY, a protective reagent, and bronchoalveolar lavage fluid, spleen, lymph nodes, and serum collected 2-5 weeks later. Cultured spleen or lymph node cells were stimulated with HKY. Proliferation of HKY-stimulated spleen or lymph node cells was tested by Alamar Blue reduction and flow cytometry. Cytokines from lymphocyte supernatants and antibody to glycans in serum collected from HKY-vaccinated mice were measured by ELISA. The results show that HKY promoted spleen cell and lymph node cell proliferation from HKY-vaccinated mice but not from PBS-vaccinated control mice (all P<0.05). Cytokine measurement showed HKY significantly promoted IFNγ, IL-6 and IL-17A production by spleen cells and lymph node cells (all P<0.05 and P<0.01, respectively). Cytokine production by HKY-stimulated cells from PBS-vaccinated mice was lower than those from HKY-vaccinated (P<0.05). Cytokines in BAL from HKY-vaccinated were higher, 1.7-fold for IFNγ and 2.1-fold for TNFα, than in BAL from PBS-vaccinated. Flow cytometry of lymphocytes from HKY-vaccinated showed 52% of CD3(+) or 56% of CD8(+) cells exhibited cell division after stimulation with HKY, compared to non-stimulated controls (26 or 23%, respectively) or HKY-stimulated cells from PBS-vaccinated (31 or 34%). HKY also induced antibody against Saccharomyces glucan and mannan with titers 4- or 2-fold, respectively, above that in unvaccinated. Taken together, the results suggested that HKY vaccination induces significant and specific Th1 type cellular immune responses and antibodies to glucan and mannan.


Assuntos
Antígenos de Fungos/imunologia , Vacinas Fúngicas/imunologia , Temperatura Alta , Saccharomyces cerevisiae/imunologia , Vacinas de Produtos Inativados/imunologia , Animais , Aspergilose/imunologia , Aspergilose/prevenção & controle , Coccidioidomicose/imunologia , Coccidioidomicose/prevenção & controle , Vacinas Fúngicas/administração & dosagem , Linfonodos/citologia , Linfonodos/imunologia , Linfonodos/microbiologia , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Baço/citologia , Baço/imunologia , Baço/microbiologia , Vacinas de Produtos Inativados/administração & dosagem
3.
Glycoconj J ; 27(7-9): 697-702, 2010 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-21110087

RESUMO

A conjugate of C. dubliniensis cell-wall mannan and human serum albumin (HSA) induced significant level of anti-mannan IgGs in sera of immunized rabbits, whereas mannan alone was not immunogenic. Binding affinities of anti-mannan IgGs induced by the conjugate were evaluated by inhibition ELISA (iELISA) using mannooligosaccharides (dimer-octamer), derived from the side chains of C. dubliniensis mannan, as the inhibitors. Inhibition power of the mannooligosaccharides increased exponentially with their size, with dimer being the weakest (IC(50) = 4 mmol/L) and heptamer/octamer the strongest inhibitors (IC(50) = 0.01 mmol/L). In addition, the mannooligosaccharides proved effective as inhibitors against antiserum obtained from rabbits immunized with C. dubliniensis heat-killed cells, demonstrating a high correlation in the IC(50) values with anti-conjugate serum (Pearson's correlation coefficient r = 0.98; P < 0.01). These findings suggest that a) the mannooligosaccharides comprising the side chains of C. dubliniensis mannan may represent relevant points of interaction with host immune system during infection and b) anti-mannan antibodies induced by the two antigens (the mannan conjugate and the yeast) are of similar specificities.


Assuntos
Candida/imunologia , Vacinas Fúngicas/imunologia , Mananas/imunologia , Oligossacarídeos/imunologia , Animais , Parede Celular/química , Parede Celular/imunologia , Feminino , Vacinas Fúngicas/química , Humanos , Soros Imunes , Imunoglobulina G/sangue , Mananas/química , Oligossacarídeos/química , Coelhos , Albumina Sérica/imunologia , Vacinas Conjugadas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...